Pediatric Support and Services
A cancer diagnosis affects more than just a child’s physical health.
Sylvester offers a wide range of psychological and psychosocial services to ensure that the academic, social, and other delicate areas of a child’s development are disrupted as little as possible during treatment. Physicians. nurses, psychologists, social workers, and child life specialists collaborate to ensure that children receive the best possible mental and physical care.
Led by Winsome Thompson, Ph.D., the multidisciplinary team has two primary goals:
- To provide psychological support to patients and their families
- To provide neuropsychological evaluations, as cancer and blood disorders (and their treatment) may have negative effects on several aspects of a child’s cognitive functioning
To counter any negative cognitive effects from chronic diseases, Daniel Armstrong, Ph.D., has established the Second Chance Program to provide targeted intervention to children and their families. These interventions assist with areas of cognitive and academic difficulty associated with disease and treatment and help to prevent such difficulty whenever possible.
The Psychology Service participates in a variety of clinical trials and research studies. This includes administering the neuropsychological components of protocols for our patients enrolled in Children’s Oncology Group (COG) and National Institutes of Health (NIH) clinical trials.
The Miller School of Medicine’s pediatric survivorship program is one of the oldest in the nation, following patients and families for over twenty years. The program provides continued clinical care for survivors and conducts important research in pediatric hematology/oncology.
The program provides a medical home where children receive ongoing monitoring and multidisciplinary treatment in cardiology, developmental pediatrics, psychology, oncology, integrative medicine, nutrition, and exercise.
Long-term treatment and observation of survivors is critical to learning more about pediatric cancer and developing treatments for future patients.